Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Orbus acquires Midamor and Moduret in Canada

May 14, 2004

Modified-release lercanidipine to be developed for Japanese market

May 14, 2004

Forbes Medi-Tech describes sterol-NSAID conjugates for cardiovascular disease and other uses

May 14, 2004

Treatment commences in Trinam phase II study

May 13, 2004

Insight into mechanism of action of AGI-1067

May 12, 2004

Novel Rho kinase inhibitors prepared and tested at Kirin Brewery

May 7, 2004

Melatonin reduces blood pressure in patients with type 1 diabetes

May 7, 2004

Voluntary withdrawal of marketing authorization for Tikosyn in E.U.

May 6, 2004

New adenosine A1 agonists, their preparation and use, reported by GSK team

May 5, 2004

New urotensin II antagonists covered by Actelion patent

May 5, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....